You are here

cancer

BioDelivery Sciences: A Bet on FDA Approval

Seeking Alpha

Fri, 03/6/09 - 09:59 am

BioDelivery Sciences

Genentech Provokes Doctors’ Ire With Costly Avastin Trial

Bloomberg

Thu, 02/26/09 - 08:01 am

Onyx revenue nearly doubles as Nexavar sales rise; results surpass analyst expectations

Yahoo/AP

Tue, 02/24/09 - 06:09 am

ONYX Pharmaceuticals

Spicing Up the Biotech Portfolio with Microcaps CuraGen and Curis

Seeking Alpha

Mon, 02/23/09 - 10:47 am

Novogen to Focus on Oncology Program

Yahoo

Fri, 02/13/09 - 10:49 am

Enzon Announces IND Acceptance for Its Survivin Antagonist

Yahoo

Tue, 02/10/09 - 08:25 am

Survivin antagonist

Cell Therapeutics Is Down but Not Out

Seeking Alpha

Tue, 02/3/09 - 07:57 am

Cell Therapeutics

Spectrum Pharmaceuticals

Synta's billion-dollar drug nears end of Phase III

Fierce Biotech

Mon, 02/2/09 - 10:43 am

Medarex says FDA approves testing of cancer drug

Yahoo/AP

Wed, 01/28/09 - 09:51 am

Soaring Cancer Drug Costs May Cripple Medicare

Businessweek

Wed, 01/28/09 - 09:04 am

Onyx, a Sweet Deal for Bayer?

Businessweek

Wed, 01/28/09 - 07:43 am

ONYX Pharmaceuticals

Why Medicare Pays So Much for Cancer Drugs

WSJ Online

Tue, 01/27/09 - 05:50 pm

Antisoma to Sell U.S. Rights to Leukemia Drug by June

Bloomberg

Mon, 01/26/09 - 11:33 am

GeoPharma gets $2.5 million for cancer business

Bizjournals.com

Mon, 01/26/09 - 11:31 am

Trident Biotech

Seattle Genetics, FDA agree on cancer study design

Yahoo/AP

Wed, 01/21/09 - 04:29 pm

Seattle Genetics

Genentech could see cancer study results in April

Yahoo/AP

Wed, 01/21/09 - 10:44 am

Novartis gets approval to market 4 drugs in Japan

Yahoo/AP

Wed, 01/21/09 - 06:56 am

macular degeneration

Roche to hit top in cancer sales by 2012

Fierce Pharma

Tue, 01/20/09 - 10:15 am

Liquidia, Abbott team up to target cancer

Bizjournals.com

Thu, 01/8/09 - 07:07 am

Abbott Laboratories

Immunogen and Exelixis Defy the Recession

Seeking Alpha

Mon, 12/22/08 - 07:47 am

Pages